Style | Citing Format |
---|---|
MLA | Hassanzadeh F, et al.. "Synthesis, Cytotoxic Effect Assessment and Molecular Docking Studies of Disubstituted Thiadiazole Including Oxadiazole As Hybrid Component." Hacettepe University Journal of the Faculty of Pharmacy, vol. 42, no. 4, 2022, pp. 228-237. |
APA | Hassanzadeh F, Jafari E, Zarei S, Sadeghialiabadi H (2022). Synthesis, Cytotoxic Effect Assessment and Molecular Docking Studies of Disubstituted Thiadiazole Including Oxadiazole As Hybrid Component. Hacettepe University Journal of the Faculty of Pharmacy, 42(4), 228-237. |
Chicago | Hassanzadeh F, Jafari E, Zarei S, Sadeghialiabadi H. "Synthesis, Cytotoxic Effect Assessment and Molecular Docking Studies of Disubstituted Thiadiazole Including Oxadiazole As Hybrid Component." Hacettepe University Journal of the Faculty of Pharmacy 42, no. 4 (2022): 228-237. |
Harvard | Hassanzadeh F et al. (2022) 'Synthesis, Cytotoxic Effect Assessment and Molecular Docking Studies of Disubstituted Thiadiazole Including Oxadiazole As Hybrid Component', Hacettepe University Journal of the Faculty of Pharmacy, 42(4), pp. 228-237. |
Vancouver | Hassanzadeh F, Jafari E, Zarei S, Sadeghialiabadi H. Synthesis, Cytotoxic Effect Assessment and Molecular Docking Studies of Disubstituted Thiadiazole Including Oxadiazole As Hybrid Component. Hacettepe University Journal of the Faculty of Pharmacy. 2022;42(4):228-237. |
BibTex | @article{ author = {Hassanzadeh F and Jafari E and Zarei S and Sadeghialiabadi H}, title = {Synthesis, Cytotoxic Effect Assessment and Molecular Docking Studies of Disubstituted Thiadiazole Including Oxadiazole As Hybrid Component}, journal = {Hacettepe University Journal of the Faculty of Pharmacy}, volume = {42}, number = {4}, pages = {228-237}, year = {2022} } |
RIS | TY - JOUR AU - Hassanzadeh F AU - Jafari E AU - Zarei S AU - Sadeghialiabadi H TI - Synthesis, Cytotoxic Effect Assessment and Molecular Docking Studies of Disubstituted Thiadiazole Including Oxadiazole As Hybrid Component JO - Hacettepe University Journal of the Faculty of Pharmacy VL - 42 IS - 4 SP - 228 EP - 237 PY - 2022 ER - |